A patented unique strain of Lactococcus lactis (LC-Plasma)
Type: Postbiotics
Application: Supplement & Nutrition
Comprehensive Immune Activation
IMMUSE™ is a novel postbiotic which is a patented strain of Lactococcus lactis that provides clinically researched immune support*. A strong immune system is crucial to maintaining good health. Today’s consumers face a constant onslaught on their immune systems from the stresses of modern life, work, diet and other lifestyle factors. With a unique mechanism of action that activates pDC (plasmacytoid dendritic cells), IMMUSE™ is a novel solution for your next immunity product.
IMMUSE™ Earns Frost & Sullivan 2021 New Product Innovation Award
Add IMMUSE™ to your next product
Contact us for product information
Related News
Kyowa Hakko’s IMMUSE™ Postbiotic Wins Inaugural “Microbiome Modulation” Industry Award
July 14, 2023PRWeb.comKyowa Hakko USA is thrilled to announce that our groundbreaking product, IMMUSE™ postbiotic for immune health, has been honored as the inaugural recipient of the the Ingredient of the Year: Microbiome Modulation category in the esteemed annual awards by NutraIngredients-USA. Read more »
Well Traveled Releases a Novel Travel Supplement Featuring IMMUSE™
April 12, 2023PRWeb.comKyowa Hakko’s IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, “Well Traveled Immune Activator." Read more »
Copyright © 1998 – 2023 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.